Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes-Reference-Cited by-同舟云学术

Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes

Published:2018-03-05 Issue:2 Volume:32 Page:135-145
ISSN:0920-3206
Container-title:Cardiovascular Drugs and Therapy
language:en
Short-container-title:Cardiovasc Drugs Ther

Author:

Birnbaum Yochai^ORCID,Bajaj Mandeep,Yang Hsiu-Chiung,Ye Yumei

Funder

AstraZeneca Schweiz

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine

Link

http://link.springer.com/article/10.1007/s10557-018-6778-x/fulltext.html

Reference38 articles.

1. Wanner C, Inzucchi SE, Zinman B. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375:1801–2.

2. Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644–57.

3. Buse JB. The LSCa. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375:1798–9.

4. Mann JFE, Orsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, et al. Liraglutide and renal outcomes in type 2 diabetes. N Engl J Med. 2017;377:839–48.

5. Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jodar E, Leiter LA, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016;375:1834–44.

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inibidores de SGLT2 e inflamassoma NLRP3: alvo potencial na doença renal do diabetes;Brazilian Journal of Nephrology;2024-12

2. SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease;Brazilian Journal of Nephrology;2024-12

3. Association of Novel Antihyperglycemic Drugs Versus Metformin With a Decrease in Asthma Exacerbations;The Journal of Allergy and Clinical Immunology: In Practice;2024-08

4. Dapagliflozin dampens liver fibrosis induced by common bile duct ligation in rats associated with the augmentation of the hepatic Sirt1/AMPK/PGC1α/FoxO1 axis;Toxicology and Applied Pharmacology;2024-08

5. Effect of dipeptidyl peptidase-4 inhibitors on tumor necrosis factor alpha levels in patients with type 2 diabetes mellitus;European Journal of Medical Research;2024-07-12